Literature DB >> 7386308

Modulation of the immune system in the mouse. 2. Drug administration following antigen sensitization.

J Cottney, J Bruin, A J Lewis.   

Abstract

The effects of administering drugs 2 days after antigen sensitization in a combined model of delayed type hypersensitivity (DTH) and humoral immunity (HI) in the mouse are described and compared with a previous study in which drugs were administered prior to sensitization using the same model. Low doses of cyclophosphamide (CY) administered after antigen sensitization were found to enhance DTH to methylated bovine serum albumin (MBSA). In addition, high doses of this drug suppressed DTH for 3 days after challenge, and then enhanced the response for a further 5 days. The HI response to sheep red blood cells (SRBC) was simultaneously suppressed by a range of CY doses. A number of different drug types demonstrated a similar pattern of dose-dependent DTH effects. However, unlike the previous study DTH enhancement was not confined to the alkylating agents. Either DTH enhancement or suppression was also observed after treatment with a number of other drugs. HI was suppressed by several drugs, in particular by a number of alkylating agents and anti-metabolites. Selective effects on one or other limbs of the immune response were observed. The mode(s) of action of drugs active in the present study are uncertain but possible explanations are discussed in terms of the elimination and subsequent recovery of specific cell populations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7386308     DOI: 10.1007/bf02024178

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  30 in total

Review 1.  Selective suppression of humoral immunity by antineoplastic drugs.

Authors:  G H Heppner; P Calabresi
Journal:  Annu Rev Pharmacol Toxicol       Date:  1976       Impact factor: 13.820

2.  Influence of cyclophosphamide on the delayed hypersensitivity in the mouse after intraperitoneal immunization.

Authors:  J A Kerckhaert
Journal:  Ann Immunol (Paris)       Date:  1974-06

3.  Selective alteration of immunocompetence with methotrexate and 5-fluorouracil.

Authors:  J A DiLorenzo; D E Griswold; C R Bareham; P Calabresi
Journal:  Cancer Res       Date:  1974-01       Impact factor: 12.701

4.  Differential effects of cyclophosphamide on the B and T cell compartments of adult mice.

Authors:  G D Stockman; L R Heim; M A South; J J Trentin
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

5.  The anti-inflammatory effect of some immunosuppressive agents.

Authors:  J E Stevens; D A Willoughby
Journal:  J Pathol       Date:  1969-02       Impact factor: 7.996

6.  Delayed hypersensitivity in mice induced by intravenous sensitization with sheep erythrocytes: evidence for tuberculin type delayed hypersensitivity of the reaction.

Authors:  A Mitsuoka; T Teramatsu; M Baba; S Morikawa; K Yasuhira
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

7.  Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.

Authors:  H K Gill; F Y Liew
Journal:  Eur J Immunol       Date:  1978-03       Impact factor: 5.532

8.  Modulation of the immune system in the mouse. 1. Drug administration prior to antigen sensitization.

Authors:  J Cottney; J Bruin; A J Lewis
Journal:  Agents Actions       Date:  1980-09

9.  Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity.

Authors:  J L Turk; D Parker
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

10.  Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.

Authors:  P W Askenase; B J Hayden; R K Gershon
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.